A microfluidic system demonstrates improved control in high-throughput drug screening, suggesting significant procedural advancements.
A scalable microfluidic system rapidly generates samples in parallel to avoid temporal variability in high-throughput, combinatorial experiments, such as drug screening.
No takes yet. Share an insight, caveat, or question.
Chris Patrick (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: